ENDP News and Press, Endo International plc From 08/17/22

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . For further details see: Wall Street Breakfast: 50 Or 75?

Endo International ( NASDAQ: ENDP ) has filed for Chapter 11 bankruptcy in New York as part of a restructuring support agreement (RSA) with the pharma company's first lien debt holders. Earlier Tuesday, Bloomberg reported that creditors were looking at putting En...

Endo Enters Into Restructuring Support Agreement with Senior Secured Debtholders to Strengthen Financial Position and Advance Ongoing Business Transformation PR Newswire Sale Transaction Would Result in a Substantial Reduction of Debt and Contemplates Purchaser-Establi...

Endo International ( NASDAQ: ENDP ) creditors are looking at putting the pharma company up for sale through a bankruptcy, likely through a Chapter 11 filing in New York, Bloomberg reported. Endo ( ENDP ) has a debt load of more than $8B and is still facing many...

3 Top Penny Stocks To Watch Right Now When it comes to finding penny stocks to buy, there are a number of strategies you can follow. And in 2022, the main factors that contribute to making money with penny stocks all have to do with what is going in the stock market. As a result of ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips It hasn’t been a good run for Endo International (NASDAQ: ENDP ), and Tuesday isn’t making it any better. Shares of ENDP stock are down more than 40% today and almost 60% from last week’s high. ...

Health Canada accepted to review a new drug submission (NDS) by Paladin Labs, a unit of Endo International ( NASDAQ: ENDP ), seeking approval of cenobamate as an adjunctive therapy to manage partial-onset seizures in adults with epilepsy who are not satisfactoril...

New Drug Filing for Cenobamate Accepted for Review in Canada and Israel PR Newswire SK Biopharmaceuticals is eligible to receive milestones for future approval and commercialization in Canada and Israel PANGYO, South Korea , Aug. 9, 2022 /...

Endo press release ( NASDAQ: ENDP ): Q2 Non-GAAP EPS of -$0.03 beats by $0.11 . Revenue of $569.11M (-20.3% Y/Y) beats by $44.54M . As of June 30, 2022, the Company had approximately $1.2 billion in unrestricted cash; $8.1 billion of debt; and a net debt t...

ENDO REPORTS SECOND-QUARTER 2022 FINANCIAL RESULTS Canada NewsWire DUBLIN , Aug. 9, 2022 /CNW/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the second-quarter ended June 30, 2022. SECOND-QUARTER FINA...